Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


While reporting financial results for the fourth quarter on Thursday, medical technology company Integra LifeSciences Holdings Corp. (IART) initiated adjusted earnings and revenue guidance for the full-year 2021 and for the first quarter.


RTTNews | Feb 18, 2021 06:30AM EST

06:30 Thursday, February 18, 2021 (RTTNews.com) - While reporting financial results for the fourth quarter on Thursday, medical technology company Integra LifeSciences Holdings Corp. (IART) initiated adjusted earnings and revenue guidance for the full-year 2021 and for the first quarter.

For fiscal 2021, the company now projects adjusted earnings in a range of $2.86 to $2.93 per share on revenues between $1.520 billion and $1.535 billion, with organic revenue growth of 12 to 13 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.92 per share on revenues of $1.54 billion for the year. Analysts' estimates typically exclude special items.

For the first quarter, the company expects adjusted earnings in a range of $0.54 to $0.58 per share on revenues between $345 million and $355 million, with organic revenue growth of flat to 3 percent.

The Street is looking for earnings of $0.64 per share on revenues of $359.90 million for the quarter.

Read the original article on RTTNews ( https://www.rttnews.com/3170752/integra-lifesciences-guides-fy21-adj-eps-in-line-with-view-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC